Lexeo Therapeutics, Inc.'s total assets for Q1 2026 were $250.36M, a decrease of -6.82% from the previous quarter. LXEO total liabilities were $18.86M for the fiscal quarter, a -14.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.